GUASTAFIERRO, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 1.596
EU - Europa 520
AS - Asia 279
AF - Africa 21
SA - Sud America 20
Totale 2.436
Nazione #
US - Stati Uniti d'America 1.588
SE - Svezia 205
IN - India 100
IT - Italia 100
SG - Singapore 93
CN - Cina 79
UA - Ucraina 67
FI - Finlandia 53
DE - Germania 26
TG - Togo 20
AR - Argentina 18
RO - Romania 18
GB - Regno Unito 13
BG - Bulgaria 12
BE - Belgio 9
IE - Irlanda 5
NL - Olanda 5
BZ - Belize 4
CA - Canada 4
IR - Iran 3
CL - Cile 2
HK - Hong Kong 2
JP - Giappone 2
CH - Svizzera 1
DK - Danimarca 1
FR - Francia 1
HU - Ungheria 1
LU - Lussemburgo 1
PL - Polonia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 2.436
Città #
Chandler 233
Fairfield 231
Woodbridge 103
Ashburn 102
Houston 83
Wilmington 82
Cambridge 76
Ann Arbor 65
Seattle 65
Beijing 62
Singapore 61
Rome 49
Princeton 48
Plano 46
San Diego 25
New York 24
Boston 23
Jacksonville 23
Lomé 20
San Paolo di Civitate 19
Federal 18
Andover 15
Lawrence 14
Millbury 14
Des Moines 13
Boardman 11
Falls Church 11
Sofia 11
Dearborn 10
Brussels 9
Bühl 8
Helsinki 8
San Jose 8
Santa Clara 8
Norwalk 7
Phoenix 7
Albuquerque 6
Cagliari 6
Las Vegas 6
Pune 6
Dublin 5
Fremont 5
Milan 5
Belize City 4
Catania 4
London 4
Redmond 4
San Mateo 4
Fasano 3
Hefei 3
Kunming 3
Leawood 3
Mannheim 3
Naples 3
Sacramento 3
Toronto 3
Amsterdam 2
Atlanta 2
Changsha 2
Columbus 2
Hong Kong 2
Indiana 2
Putignano 2
Southend 2
Tokyo 2
Verona 2
Zanjan 2
Augusta 1
Baotou 1
Bern 1
Bremen 1
Brentford 1
Budapest 1
Champs-sur-marne 1
Chicago 1
Chongqing 1
Copenhagen 1
Cornaredo 1
Edinburgh 1
Frankfurt am Main 1
Grafing 1
Hounslow 1
Jinan 1
Kindsbach 1
Laurel 1
Luxembourg 1
Nanchang 1
Nanjing 1
Noventa Di Piave 1
Portland 1
San Francisco 1
Sanming 1
Santiago 1
Seversk 1
Shenyang 1
Silverton 1
Tappahannock 1
Warsaw 1
Winnipeg 1
Totale 1.749
Nome #
Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line 115
Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity. 99
Analysis of the machinery and intermediates of the 5hmC-mediated DNA demethylation pathway in aging on samples from the MARKAGE Study 90
ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites 88
PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression 87
Poly(ADP-ribosyl)ation affects stabilization of Che-1 protein in response to DNA damage 83
Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line 78
CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery 76
DNA hydroxymethylation levels are altered in blood cells from Down syndrome persons enrolled in the MARK-AGE project 71
Validation of suitable internal control genes for expression studies in aging 70
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood 68
Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity 67
ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites 67
Validation of suitable internal control genes for expression studies in aging. 67
Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity 66
Poly(ADP-ribosyl)ation affects stabilization of Che-1 protein in response to DNA damage 65
ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites 61
Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity 60
Validation of suitable internal control genes for expression studies in aging 57
Age-dependent expression of DNMT1 and DNMT3B in PBMCs from a large European population enrolled in the MARK-AGE study 57
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells 57
Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription 54
PARP-1 meets Che-1 in the cell response to DNA damage 53
Crosstalk between poly(ADP-ribosyl)ation and DNA methylation in the regulation of gene expression: “Poly(ADP-polymers) depletion by PARG Overexpression Leads to Methylation of the Dnmt1 Promoter, Downregulation of Gene and Genome-Wide Hypomethylation” 52
Ctcf marks the CpGs that are maintained non methylated by PARP activity at Igf2/H19 locus 49
CTCF-PARP1-Dnmt1 complex at Igf2-H19 locus 49
PARP-1 cooperates to Che-1 stabilization in response to DNA damage 47
Balancing of PARylated PARP-1 maintains genomic methylation pattern 47
Proteome analysis of protein partners to nucleosomes containing canonical H2A or the variant histones H2A.Z or H2A.X. 44
PARP-1 controls Snail expression in epithelial cancer cells exposed to doxorubicin 43
La metilazione del DNA e la poli(ADP-ribosil)azione sono interconnesse nel controllo dell’imprinting?. 42
Ctcf marks the CpGs that are maintained non methylated by PARP activity at Igf2/H19 locus 42
Treatment of M14 melanoma cell line with PJ-34 leads to growth impairment and cell death 41
CTCF transcriptional factor is involved in the crosstalk between poly(ADP-ribosyl)ation and DNA methylation. 38
La poli-ADP-ribosilazione protegge lo stato non metilato della regione promotrice di DNMT1 38
PARP-1 and Che-1: two important players in the cell response to DNA damage 33
Epigenetic reprogramming in peripheral mononuclear cells from multiple sclerosis patients 33
CTCF is involved in the “crosstalk” between poly(ADP-ribosyl)ation and DNA methylation 32
Poly(ADPribosyl)ation of Che-1 in response to DNA damage affects its stabilization 31
PARylation controls the expression of Dnmt1 30
Methylation status of Dnmt1 promoter depends on poly(ADPribosyl)ation 28
Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation pattern 28
Role of PARP-1 in the regulation of Snail expression in epithelial cancer cells 27
PARylation controls the expression of the DNA hydroxylase TET1 27
The role of PARylation in the regulation of the Cancer Testis Antigen TSP50 expression 27
PARylation controls the expression level of Dnmt1 22
Totale 2.506
Categoria #
all - tutte 6.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020403 0 0 7 19 49 46 57 64 51 54 40 16
2020/2021227 16 56 29 25 2 8 2 26 17 30 13 3
2021/2022488 4 26 32 24 83 44 2 36 46 48 50 93
2022/2023668 131 142 72 65 86 68 18 19 37 4 25 1
2023/2024213 15 42 1 17 10 42 1 26 1 22 14 22
2024/202579 25 54 0 0 0 0 0 0 0 0 0 0
Totale 2.506